MAYZENT

Identification of Mayzent

No description

Google image searchProduct monograph

Active ingredient

siponimod, 0.25 MG

DIN: 02496429

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 24-APR-2020

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AE — Sphingosine-1-phosphate (S1P) receptor modulators (ATC, ATC/DDD)
• L04AE03 — SIPONIMOD (ATC/DDD)

External Links for Mayzent

Search on Google

• Mayzent side effects
• Mayzent dosage
• siponimod side effects
• siponimod dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find mayzent photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.